JAMA 311 , 18891900 (2014)
However, clinical data confirms that weight loss is significantly slower with microdosing compared to standard therapeutic doses, often resulting in much less total weight loss over the same period
The overall incidence of adverse events for the 8-trial, short-term, placebo-controlled pool in adult patients treated with dapagliflozin 10 mg and metformin HCl was 60.3% compared to 58.2% for the placebo and metformin HCl group
People with sensitive skin should avoid skin irritation by patch-testing first or avoiding these products entirely
The risk of yo-yo effects, where patients lose muscle on the drug and regain fat after stopping, is a real concern
This should be achieved while minimising the time in range for hypoglycaemia, aiming for less than 4% in a range of less than 3.9 mmol/L